Global Polyp Removal Device Market Size By Type (Product Type I, Product Type II), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Polyp Removal Device Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.1 billion by 2031, expanding at a CAGR of 7.1% during the forecast period from 2023 to 2031. Polyp removal devices are integral to the detection and treatment of precancerous polyps, particularly in colorectal cancer screening and prevention. Market growth is driven by the increasing prevalence of colorectal cancer, rising awareness of early detection, advancements in endoscopic technologies, and the growing adoption of minimally invasive procedures.

Drivers:

1. Increasing Prevalence of Colorectal Cancer:

Colorectal cancer remains one of the most common cancers globally. Early detection through routine screening procedures such as colonoscopy, which often includes polyp removal, significantly reduces mortality rates. This has led to a growing demand for advanced polypectomy devices.

2. Advancements in Endoscopic Technology:

Innovations such as high-definition imaging, disposable snares, and electrosurgical devices have improved the efficacy and safety of polyp removal. These technological upgrades support market expansion by increasing physician adoption and procedural outcomes.

3. Aging Population and Screening Guidelines:

The aging global population, especially in developed regions, is more prone to gastrointestinal disorders. Concurrently, healthcare guidelines now recommend earlier and more frequent screenings, leading to increased procedures involving polyp removal.

Restraints:

1. High Cost of Endoscopic Procedures:

While technologically advanced devices improve outcomes, their high costs can limit adoption, especially in low- and middle-income regions where healthcare budgets are constrained.

2. Limited Access in Emerging Economies:

Many developing countries still lack adequate screening infrastructure and trained personnel, which restricts the widespread use of polyp removal devices.

Opportunity:

1. Expansion into Untapped Markets:

There is significant growth potential in regions such as Asia-Pacific and Latin America due to rising healthcare awareness, improving medical infrastructure, and government-led screening initiatives.

2. Demand for Single-Use Devices:

To reduce cross-contamination risks and improve procedural safety, there is increasing interest in single-use polyp removal tools, which presents lucrative opportunities for device manufacturers.

Market by System Type Insights:

By system type, cold snare polypectomy devices dominated the market in 2023 due to their safety, simplicity, and widespread clinical adoption. They are increasingly preferred for removing small and benign polyps. However, electrosurgical snares are anticipated to grow at a faster rate owing to their precision and suitability for larger or complex polyps.

Market by End-use Insights:

Hospitals accounted for the largest share in 2023, supported by their capacity for high-volume procedures and access to specialized gastroenterologists. However, ambulatory surgical centers (ASCs) are gaining traction due to cost-effectiveness and reduced procedural wait times, making them a high-growth segment.

Market by Regional Insights:

North America led the market in 2023, driven by robust healthcare infrastructure, high awareness levels, and favorable reimbursement policies. Meanwhile, Asia-Pacific is expected to register the fastest growth rate through 2031, bolstered by rising government screening programs, a large target population, and improved healthcare access.

Competitive Scenario:

Key players in the global polyp removal device market include:

Boston Scientific Corporation

Olympus Corporation

Medtronic plc

ConMed Corporation

Steris PLC

Cook Medical

Micro-Tech Endoscopy

EndoGastric Solutions

US Endoscopy

Cantel Medical (a STERIS company)

These companies are focusing on R&D investments, geographic expansion, and the launch of advanced single-use or hybrid polypectomy devices. For example:

In 2023, Boston Scientific launched its next-gen cold snare with improved ergonomics and polyp retrieval accuracy.

Olympus introduced a new disposable electrosurgical snare in 2024 tailored for outpatient settings.

Cook Medical partnered with regional distributors in Southeast Asia in 2025 to improve access to its endoscopic product portfolio.

Scope of Work – Global Polyp Removal Device Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type, By End-use, By Region

Growth Drivers Rising colorectal cancer cases, aging population, improved screening techniques

Opportunities Demand for single-use devices, expansion in Asia-Pacific

Key Market Developments:

April 2023: Medtronic launched a new series of cold snares optimized for minimally invasive procedures with enhanced cutting precision.

August 2024: Olympus partnered with a global health organization to promote colorectal cancer screening awareness in Latin America.

February 2025: C